Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Research and Development
Owlstone, FDA's OSEL partner to develop VOC ID methods
By
LabPulse.com staff writers
Owlstone Medical entered a research collaboration agreement with the FDA's Center for Devices and Radiological Health Office of Science and Engineering Laboratories (OSEL) to develop methods of identifying volatile organic compounds (VOCs) in breath.
September 30, 2024
Cepheid partners with Fleming Initiative on antimicrobial resistance
By
LabPulse.com staff writers
Diagnostics firm Cepheid has entered a partnership with the Fleming Initiative, a global collaboration established by the Imperial College Healthcare National Health Service Trust and Imperial College London to combat antimicrobial resistance.
September 26, 2024
NIH establishes pandemic preparedness research network
By
LabPulse.com staff writers
The U.S. National Institutes of Health (NIH) has established a pandemic preparedness research network for research on the pathogens that are most likely to threaten human health.
September 19, 2024
Humana, UnitedHealthcare change Z-code requirements for molecular diagnostic test claims
By
LabPulse.com staff writers
Among the tests in focus are certain RNA- and DNA-based tests.
September 19, 2024
Multiregional clinical trial data on FDA watch for U.S. applicability
By
LabPulse.com staff writers
Pivotal trials drawing on foreign clinical data in focus.
September 16, 2024
Mount Sinai Health gets $3.26M NIH grant for undiagnosed diseases center
By
LabPulse.com staff writers
Mount Sinai Health received a four-year, $3.26 million grant from the U.S. National Institutes of Health (NIH) to establish the new Mount Sinai Center for Undiagnosed Diseases, the first Undiagnosed Diseases Network site in the New York metropolitan area.
September 17, 2024
HudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencing
By
LabPulse.com staff writers
Scientists at the HudsonAlpha Institute for Biotechnology in Huntsville, AL, have been awarded a five-year, $2.9 million U.S. National Institutes of Health (NIH) grant to identify genetic contributors to rare diseases in children.
September 6, 2024
Seegene, Springer Nature launch PCR innovation program
By
LabPulse.com staff writers
Molecular diagnostics firm Seegene and Springer Nature have launched a new project for the development of diagnostic assays, as part of their ongoing strategic partnership.
September 3, 2024
Lumos Diagnostics extends deal to advance POC liver monitoring test to trials
By
LabPulse.com staff writers
Lumos Diagnostics is expanding an existing deal with the Burnet Diagnostics Initiative that will advance a new point-of-care (POC) test for monitoring liver health in an upcoming clinical trial.
August 28, 2024
Qiagen ventures into chronic disease CDx
By
LabPulse.com staff writers
Qiagen has expanded its agreement with AstraZeneca beyond oncology.
August 29, 2024
Scale Bio launches 100M cell challenge research initiative
By
LabPulse.com staff writers
Scale Biosciences, in collaboration with Ultima Genomics and Nvidia, has launched a global initiative for single-cell research projects aimed at collectively analyzing 100 million cells or more across diverse biological systems and research areas.
August 19, 2024
Alpenglow Biosciences lands $24M for 3D pathology platform
By
LabPulse.com staff writers
Company gets boost to commercialize direct-to-digital pathology platform and AI.
August 15, 2024
Page 1 of 41
Next Page